CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 161 filers reported holding CLOVIS ONCOLOGY INC in Q3 2019. The put-call ratio across all filers is 1.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $207,000 | -46.5% | 13,942 | -10.5% | 0.01% | -47.4% |
| Q1 2019 | $387,000 | +38.7% | 15,582 | +0.4% | 0.02% | +11.8% |
| Q4 2018 | $279,000 | -51.3% | 15,522 | -20.4% | 0.02% | -22.7% |
| Q3 2018 | $573,000 | -29.3% | 19,496 | +9.5% | 0.02% | -31.2% |
| Q2 2018 | $810,000 | -12.7% | 17,804 | +1.3% | 0.03% | -13.5% |
| Q1 2018 | $928,000 | -29.2% | 17,577 | -8.8% | 0.04% | -26.0% |
| Q4 2017 | $1,310,000 | -25.3% | 19,263 | -9.5% | 0.05% | -31.5% |
| Q3 2017 | $1,753,000 | +564.0% | 21,278 | +10.7% | 0.07% | +461.5% |
| Q2 2016 | $264,000 | -30.3% | 19,227 | -2.5% | 0.01% | -35.0% |
| Q1 2016 | $379,000 | -55.6% | 19,729 | -19.0% | 0.02% | -50.0% |
| Q4 2015 | $853,000 | -61.5% | 24,359 | +1.1% | 0.04% | -68.3% |
| Q3 2015 | $2,217,000 | – | 24,105 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $45,630,648,000 | 43.63% |
| EcoR1 Capital, LLC | 384,348 | $21,523,000 | 10.89% |
| Palo Alto Investors LP | 2,102,857 | $117,760,000 | 6.91% |
| NEA Management Company, LLC | 2,279,781 | $127,668,000 | 6.19% |
| Redmile Group, LLC | 721,632 | $40,411,000 | 4.40% |
| Opaleye Management Inc. | 140,000 | $7,840,000 | 3.96% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 790,555 | $44,271,000 | 2.63% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 339,327 | $19,002,000 | 2.31% |
| PFM Health Sciences, LP | 1,725,126 | $96,607,000 | 2.26% |
| HARBOURVEST PARTNERS LLC | 51,037 | $2,858,000 | 1.50% |